公开(公告)号：WO2009151457A1

公开(公告)日：2009-12-17

申请号：PCT/US2008/066888

申请日：2008-06-13

Applicant: SCIELE PHARMA, INC. ,  EDWARDS, John, B. ,  ERLANDSON, Lori, T. ,  GRIFFIN, Edward, Nicholas ,  ROBERTS, Alan, T.

Inventor： EDWARDS, John, B. ,  ERLANDSON, Lori, T. ,  GRIFFIN, Edward, Nicholas ,  ROBERTS, Alan, T.

IPC: A23L1/30 ,  A23L1/302 ,  A61K31/202 ,  A61K31/519

CPC classification number: A61K31/202 ,  A23K20/158 ,  A23K20/174 ,  A23L33/12 ,  A23L33/15 ,  A23L33/16 ,  A23V2002/00 ,  A61K31/519 ,  A23V2250/1592 ,  A23V2250/72 ,  A23V2250/705 ,  A23V2250/1578 ,  A23V2250/1588 ,  A23V2250/1642 ,  A23V2250/7056 ,  A23V2250/187 ,  A23V2250/1868 ,  A23V2250/7042 ,  A23V2250/7044 ,  A23V2250/7052 ,  A23V2250/706 ,  A23V2250/7106 ,  A23V2250/712 ,  A23V2250/708 ,  A23V2250/7046 ,  A23V2250/161 ,  A23V2250/1626 ,  A23V2250/1612 ,  A23V2250/1608

Abstract: Compositions and methods for improving the nutritional and physiological status of a woman and her child during all stages of pregnancy are provided herein. The compositions are particularly useful for the neurological, visual, and cognitive development of an embryo, fetus, or infant and the nutritional and physiological well-being of the mother, fetus, and infant. The compositions contain one or more folates and one or more essential fatty acids (EFA), such as an omega-3 and/or omega-6 fatty acid. The one or more folates and essential fatty acid may be administered together or in separate dosage units. The compositions may optionally contain other vitamins, minerals, and ingredients.

Abstract translation: 本文提供了在妊娠期间改善妇女及其小孩的营养和生理状态的组合物和方法。 该组合物特别可用于胚胎，胎儿或婴儿的神经学，视觉和认知发育以及母亲，胎儿和婴儿的营养和生理健康。 组合物含有一种或多种叶酸酯和一种或多种必需脂肪酸（EFA），例如ω-3和/或ω-6脂肪酸。 一种或多种叶酸和必需脂肪酸可以一起施用或以不同的剂量单位施用。 组合物可任选地含有其它维生素，矿物质和成分。

公开(公告)号：WO2009106528A2

公开(公告)日：2009-09-03

申请号：PCT/EP2009052186

申请日：2009-02-25

Applicant: NESTEC SA ,  BERROCAL RAFAEL ,  FICHOT MARIE-CLAIRE ,  SPRENGER NORBERT

Inventor： BERROCAL RAFAEL ,  FICHOT MARIE-CLAIRE ,  SPRENGER NORBERT

IPC: C07H3/04 ,  C07H3/06

CPC classification number: A23L1/305 ,  A23L33/10 ,  A23L33/17 ,  A23V2002/00 ,  C07H3/04 ,  C07H3/06 ,  A23V2250/28 ,  A23V2250/1872 ,  A23V2250/1874 ,  A23V2250/702 ,  A23V2250/71 ,  A23V2250/7142 ,  A23V2250/708 ,  A23V2250/704 ,  A23V2250/1614 ,  A23V2250/16 ,  A23V2250/1582 ,  A23V2250/1578 ,  A23V2250/1618 ,  A23V2250/161 ,  A23V2250/1612 ,  A23V2250/1626 ,  A23V2250/1592 ,  A23V2250/1598 ,  A23V2250/1588 ,  A23V2250/1642

Abstract: An oligosaccharide ingredient comprising glycosylated amino acids and peptides of the general formula RnSacm where R is an amino acid residue, Sac is a monosaccharide selected from the group comprising N-acetyl-neuraminic acid, N-acetyl galactosamine and galactose, n has a value between 1 and 10 with the proviso that if n has the value 1 R is a threonine residue or a serine residue and if n has a value between 2 and 10 the peptide contains at least one threonine or serine residue, m has a value between 2 and 4 and at least 20 mol% of the ingredient is N-acetyl-neuraminic acid.

Abstract translation: 包含糖基化氨基酸的寡糖成分和通式RnSacm的肽，其中R是氨基酸残基，Sac是选自N-乙酰 - 神经氨酸，N-乙酰半乳糖胺和半乳糖的单糖，n具有在 1和10，条件是如果n具有值1，R是苏氨酸残基或丝氨酸残基，如果n具有2至10的值，则肽含有至少一个苏氨酸或丝氨酸残基，m具有2和 4和至少20mol％的成分是N-乙酰神经氨酸。

公开(公告)号：WO2007126990A2

公开(公告)日：2007-11-08

申请号：PCT/US2007/007817

申请日：2007-03-27

Applicant: NESTEC S.A. ,  CZARNECKI-MAULDEN, Gail ,  FILIPI, Ivan

Inventor： CZARNECKI-MAULDEN, Gail ,  FILIPI, Ivan

IPC: A61K39/395

CPC classification number: A61K35/744 ,  A23K10/18 ,  A23K20/163 ,  A23K20/174 ,  A23K20/179 ,  A23K20/20 ,  A23K20/22 ,  A23K20/24 ,  A23K20/30 ,  A23K40/30 ,  A23K50/40 ,  A23L33/135 ,  A23L33/15 ,  A23L33/16 ,  A23L33/21 ,  A23V2002/00 ,  A61K9/0056 ,  A61K9/5063 ,  A61K31/01 ,  A61K31/145 ,  A61K31/355 ,  A61K31/375 ,  A61K35/745 ,  A61K35/747 ,  A61K36/064 ,  A61K38/00 ,  A61K45/06 ,  G09B5/02 ,  G09B19/0092 ,  A61K2300/00 ,  A23V2200/08 ,  A23V2250/0644 ,  A23V2250/1578 ,  A23V2250/1588 ,  A23V2250/1592 ,  A23V2250/16 ,  A23V2250/161 ,  A23V2250/1612 ,  A23V2250/1614 ,  A23V2250/1618 ,  A23V2250/1626 ,  A23V2250/1642 ,  A23V2250/18 ,  A23V2250/708 ,  A23V2250/712

Abstract: Dietary supplements comprising at least one probiotic and at least one of animal digest, dried brewers yeast, vitamin C; vitamin E, beta carotene, zinc proteinate, manganese proteinate, ferrous sulfate, copper proteinate, calcium iodate, and sodium selenite. The probiotics and other ingredients are present in the supplement in amounts sufficient to enhance the palatability of the probiotics and compositions containing the probiotics, enhance the immune system to augment the beneficial effects of the probiotics, or extend the life of the probiotics.

Abstract translation: 膳食补充剂包含至少一种益生菌和至少一种动物消化，干酿酒酵母，维生素C; 维生素E，β-胡萝卜素，蛋白质锌，蛋白质锰，硫酸亚铁，蛋白质铜，碘酸钙和亚硒酸钠。 益生菌和其他成分以足以增加益生菌和含有益生菌的组合物的适口性的量存在于补充物中，增强免疫系统以增加益生菌的有益效果，或延长益生菌的寿命。

公开(公告)号：WO2007038685A3

公开(公告)日：2007-10-25

申请号：PCT/US2006037904

申请日：2006-09-27

Applicant: CONSTELLATION BRANDS INC ,  SHRIKHANDE ANIL J ,  WANG HAIBO ,  KUPINA STEVE A

Inventor： SHRIKHANDE ANIL J ,  WANG HAIBO ,  KUPINA STEVE A

IPC: A61K36/87 ,  A23L2/00

CPC classification number: A23L2/39 ,  A23L2/52 ,  A23L33/105 ,  A23L33/11 ,  A23V2002/00 ,  A61K36/87 ,  A23V2250/032 ,  A23V2250/5114 ,  A23V2250/2482 ,  A23V2200/044 ,  A23V2250/708 ,  A23V2250/2132 ,  A23V2250/702 ,  A23V2250/71 ,  A23V2250/712 ,  A23V2250/714 ,  A23V2250/704 ,  A23V2250/1578 ,  A23V2250/159 ,  A23V2250/1598 ,  A23V2250/1642 ,  A23V2250/1626 ,  A23V2250/1584 ,  A23V2250/161 ,  A23V2250/1586 ,  A23V2250/1612 ,  A23V2250/1608 ,  A23V2250/1582 ,  A23V2250/16 ,  A23V2250/213

Abstract: The present invention relates to a novel grape extract, and processes for making such, that is useful for, inter alia, treating pre-hypertension, Metabolic Syndrome and/or the conditions that comprise Metabolic Syndrome. The processes of the present invention produce a highly concentrated polyphenol product by maximizing extraction of monomeric and oligomeric procyanidins and minimizing extraction of polymeric procyanidins. The grape extract of the present invention comprises between about 5-15% monomers, about 5-20% dinners, about 3- 10% trimers, about 2-10% tetramers, and about 2-10% pentamers by weight. The grape extract of the present invention can be formulated into dietary supplements, including capsules, tablets, powders, solutions, gels, suspensions, creams, gels, and the like. These dietary supplements in, for instance, powder or solution form, may be added to nutraceuticals, foods and/or beverages to form functional nutraceutical, food, and/or beverage products.

Abstract translation: 本发明涉及一种新型葡萄提取物及其制备方法，其特别用于治疗高血压前期，代谢综合征和/或包含代谢综合征的病症。 本发明的方法通过最大化单体和低聚原花青素的提取和最小化聚合原花青素的提取来产生高度浓缩的多酚产物。 本发明的葡萄提取物包含按重量计约5-15％单体，约5-20％二聚体，约3-10％三聚体，约2-10％四聚体和约2-10％五聚体。 本发明的葡萄提取物可以配制成膳食补充剂，包括胶囊，片剂，粉剂，溶液剂，凝胶剂，混悬剂，乳膏剂，凝胶剂等。 这些以例如粉末或溶液形式的膳食补充剂可以添加到营养食品，食品和/或饮料中以形成功能性营养制品，食品和/或饮料产品。

公开(公告)号：WO2007074135A2

公开(公告)日：2007-07-05

申请号：PCT/EP2006/070122

申请日：2006-12-21

Applicant: LABORATORIOS ORDESA, S.L. ,  RIVERO URGELL, Montserrat ,  CHIFRÉ PETIT, Ricard ,  RODRÍGUEZ-PALMERO SEUMA, María ,  CAMPOY FOLGOSO, Cristina

Inventor： RIVERO URGELL, Montserrat ,  CHIFRÉ PETIT, Ricard ,  RODRÍGUEZ-PALMERO SEUMA, María ,  CAMPOY FOLGOSO, Cristina

IPC: A23L1/29 ,  A61P37/04 ,  A23L1/308 ,  A23L1/305

CPC classification number: A23L33/21 ,  A23L33/17 ,  A23L33/40 ,  A23V2002/00 ,  A23V2250/1614 ,  A23V2250/16 ,  A23V2250/1578 ,  A23V2250/1592 ,  A23V2250/161 ,  A23V2250/1642 ,  A23V2250/1588 ,  A23V2250/1598 ,  A23V2250/1612 ,  A23V2250/1626 ,  A23V2250/702 ,  A23V2250/71 ,  A23V2250/712 ,  A23V2250/714 ,  A23V2250/7042 ,  A23V2250/7044 ,  A23V2250/7052 ,  A23V2250/706 ,  A23V2250/708 ,  A23V2250/7058 ,  A23V2250/7046 ,  A23V2250/7054 ,  A23V2250/54252 ,  A23V2250/54246 ,  A23V2250/1942 ,  A23V2250/612 ,  A23V2250/5114 ,  A23V2250/61 ,  A23V2250/608 ,  A23V2250/28

Abstract: The invention relates to nutritional compositions and infant formulas comprising a combination of a colostrum-derived product and a prebiotic component. The composition of the invention provides an improvement of the regulation and stimulation of the development of the immune system.

Abstract translation: 本发明涉及包含初乳衍生产品和益生元组分的组合的营养组合物和婴儿配方。 本发明的组合物提供了对免疫系统发育的调节和刺激的改善。

公开(公告)号：WO2007073176A2

公开(公告)日：2007-06-28

申请号：PCT/NL2006000659

申请日：2006-12-22

Applicant: NUTRICIA NV ,  HAGEMAN ROBERT JOHAN JOSEPH

Inventor： HAGEMAN ROBERT JOHAN JOSEPH

CPC classification number: A61K31/202 ,  A23L33/12 ,  A23L33/15 ,  A23L33/16 ,  A23L33/17 ,  A23L33/40 ,  A23V2002/00 ,  A61K31/185 ,  A61K31/198 ,  A61K31/20 ,  A61K33/24 ,  A61K33/32 ,  A61K35/20 ,  A61K45/06 ,  A61K2300/00 ,  A23V2250/161 ,  A23V2250/1608 ,  A23V2250/302 ,  A23V2250/28 ,  A23V2250/70 ,  A23V2250/72 ,  A23V2250/705 ,  A23V2250/54252 ,  A23V2250/54246 ,  A23V2250/194 ,  A23V2200/332 ,  A23V2250/5488 ,  A23V2250/061 ,  A23V2250/0624 ,  A23V2250/1868 ,  A23V2250/187 ,  A23V2250/0616 ,  A23V2250/1618 ,  A23V2250/7052 ,  A23V2250/7056 ,  A23V2250/706 ,  A23V2250/1612 ,  A23V2250/5114 ,  A23V2250/628 ,  A23V2250/712 ,  A23V2250/708 ,  A23V2250/1626 ,  A23V2250/1642 ,  A23V2250/714 ,  A23V2200/328 ,  A23V2250/548 ,  A23V2250/608 ,  A23V2250/62 ,  A23V2250/5118 ,  A23V2250/5108 ,  A23V2250/218 ,  A23V2250/156 ,  A23V2200/304 ,  A23V2250/0644 ,  A23V2250/304 ,  A23V2250/1842

Abstract: It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical composition that comprises a/ a lipid fraction comprising at least one of docosahexaneoic acid (DHA), docosapentaenoic acid (DPA) and eicosapentaenoic acid (EPA); b/ a protein fraction comprising proteinaceous material from non-human origin which provide at least cysteine and/or taurine; and c/ a mineral fraction comprising at least one of manganese and molybdene, the health of these persons improves. Membrane function of several types of mammalian cells improves, which allows efficient treatment of immune related disorders, such as allergy, autoimmune diseases, cancer, cognitive dysfunction and other diseases of the nervous system, neuropathies, such as diabetic neuropathies and neuropathic pains, neuronal damage during insulin resistance, and gut diseases and support of the development of gut and lung function during growth or recovery.

Abstract translation: 现在已经发现，在给患有发展这种疾病的危险的患病个体或个人之后，该药物或药物组合物包含包含二十二碳六烯酸（DHA），二十二碳五烯酸（DPA）中的至少一种的脂质部分 ）和二十碳五烯酸（EPA）; b /一种蛋白质级分，其包含至少提供半胱氨酸和/或牛磺酸的来自非人源的蛋白质物质; 和c / a包含锰和钼中的至少一种的矿物部分，这些人的健康得到改善。 几种类型的哺乳动物细胞的膜功能得到改善，其允许有效治疗免疫相关疾病，例如过敏，自身免疫性疾病，癌症，认知功能障碍和其他神经系统疾病，神经病，如糖尿病性神经病和神经性疼痛，神经元损伤 在胰岛素抵抗期间，肠道疾病和支持生长或恢复期间肠和肺功能的发展。

公开(公告)号：WO2007017402A1

公开(公告)日：2007-02-15

申请号：PCT/EP2006/064769

申请日：2006-07-28

Applicant: SICIT CHEMITECH S.p.A. ,  CANDIDO, Manuela Cinzia ,  NERESINI, Massimo ,  ODELLI, Oreste ,  PIVA, Marco

Inventor： CANDIDO, Manuela Cinzia ,  NERESINI, Massimo ,  ODELLI, Oreste ,  PIVA, Marco

IPC: A23J1/10 ,  A23J1/00 ,  A23J1/12 ,  A23J1/14 ,  A23J1/20 ,  A23L1/304 ,  A23J3/32 ,  A23J3/34

CPC classification number: A23J3/32 ,  A23J1/002 ,  A23J1/004 ,  A23J1/10 ,  A23J1/12 ,  A23J1/14 ,  A23J1/20 ,  A23J3/34 ,  A23J3/341 ,  A23J3/342 ,  A23J3/348 ,  A23L33/165 ,  A23V2002/00 ,  A23V2250/1612 ,  A23V2250/54

Abstract: The invention refers to a process for the production of protein hydrolysates in composition with manganese, in particular of the type obtainable from by-products of animal origin and/or from waste and/or from leather tanning industry residues obtained before and after the tanning step.

Abstract translation: 本发明涉及用锰生产蛋白质水解物的方法，特别是可从动物来源的副产物和/或来自废物和/或从鞣制步骤之前和之后获得的皮革鞣制工业残余物获得的类型 。

公开(公告)号：WO2006034098A1

公开(公告)日：2006-03-30

申请号：PCT/US2005/033287

申请日：2005-09-19

Applicant: CAN TECHNOLOGIES, INC. ,  CARGILL, INCORPORATED ,  JOBE, Patrick, A. ,  NEWCOMB, Mark, D. ,  CALK, Clinton, B. ,  COOK, David, A. ,  ENGELMEYER, Steve ,  GOULDIE, Timothy, C. ,  KRUSA, Bradley, G. ,  LUNA, Leonardo, A. Vivas ,  NEWCOMB, Mark, D. ,  PARHAM, Brian, T. ,  VAN DE LIGT, Jennifer, L. G.

Inventor： JOBE, Patrick, A. ,  NEWCOMB, Mark, D. ,  CALK, Clinton, B. ,  COOK, David, A. ,  ENGELMEYER, Steve ,  GOULDIE, Timothy, C. ,  KRUSA, Bradley, G. ,  LUNA, Leonardo, A. Vivas ,  NEWCOMB, Mark, D. ,  PARHAM, Brian, T. ,  VAN DE LIGT, Jennifer, L. G.

IPC: A23K1/175

CPC classification number: A23K1/18 ,  A23K20/158 ,  A23K20/20 ,  A23K20/22 ,  A23K40/20 ,  A23K40/25 ,  A23K50/00 ,  A23K50/15 ,  A23L33/10 ,  A23L33/16 ,  A23V2002/00 ,  Y10S426/807 ,  A23V2250/1578 ,  A23V2250/161 ,  A23V2250/1886 ,  A23V2250/159 ,  A23V2250/16 ,  A23V2250/1642 ,  A23V2250/1592 ,  A23V2250/1588 ,  A23V2250/1584 ,  A23V2250/1598 ,  A23V2250/1612 ,  A23V2250/1626

Abstract: A mineral supplement is described herein that has a high mineral and/or nitrogen content and is capable of being formed into a pellet. The mineral supplement may comprise a heat sink that absorbs heat during processing, thus facilitating the formation of the mineral supplement as a pellet.

Abstract translation: 本文描述的矿物质补充剂具有高矿物质和/或氮含量并且能够形成颗粒。 矿物质补充剂可以包括在加工过程中吸收热量的散热器，从而促进作为颗粒形成矿物质补充剂。

公开(公告)号：WO2005087024A2

公开(公告)日：2005-09-22

申请号：PCT/FR2005000505

申请日：2005-03-03

Applicant: LARENA ,  LECLERC CHRISTIAN ,  MARTIN FLORE ,  BURCKEL ANDRE ,  RAPIN JEAN-ROBERT

Inventor： LECLERC CHRISTIAN ,  MARTIN FLORE ,  BURCKEL ANDRE ,  RAPIN JEAN-ROBERT

IPC: A23K1/175 ,  A23L1/30 ,  A23L1/304 ,  A23L1/305 ,  A61K33/06 ,  A61K33/24 ,  A61K33/26 ,  A61K33/30 ,  A61K33/32 ,  A61K33/34 ,  A61K36/06

CPC classification number: A61K33/06 ,  A23L33/14 ,  A23L33/165 ,  A23V2002/00 ,  A61K33/24 ,  A61K33/26 ,  A61K33/30 ,  A61K33/32 ,  A61K33/34 ,  A61K36/06 ,  A61K2300/00 ,  A23V2250/156 ,  A23V2250/1592 ,  A23V2250/161 ,  A23V2250/1642 ,  A23V2250/1588 ,  A23V2250/1612 ,  A23V2250/1586 ,  A23V2250/218

Abstract: The invention relates to a novel product comprising at least one type of highly bioavailable mineral, to a method for the preparation thereof, to a compound containing said product and to the uses thereof. The inventive product can be used for preparing a food compound, preferably a food additive or a dietetic product. Said compounds are particularly efficient for preventing or curing diseases related to mineral deficiency.

Abstract translation: 本发明涉及包含至少一种高生物可利用矿物的新产品，其制备方法，含有所述产品的化合物及其用途。 本发明的产品可用于制备食品化合物，优选食品添加剂或饮食产品。 所述化合物对于防止或治愈与矿物质缺乏有关的疾病特别有效。

公开(公告)号：WO2004112512A1

公开(公告)日：2004-12-29

申请号：PCT/EP2004/006469

申请日：2004-06-16

Applicant: NESTEC S.A. ,  FAURE, Magali ,  ROCHAT, Florence ,  BREUILLE, Denis ,  CORTHESY-THEULAZ, Irène

Inventor： FAURE, Magali ,  ROCHAT, Florence ,  BREUILLE, Denis ,  CORTHESY-THEULAZ, Irène

IPC: A23L1/305

CPC classification number: A61K31/198 ,  A23K20/142 ,  A23K20/147 ,  A23K50/40 ,  A23L33/175 ,  A23L33/40 ,  A23V2002/00 ,  A61K9/0095 ,  A61K31/195 ,  A61K31/401 ,  A23V2250/0642 ,  A23V2250/064 ,  A23V2250/0648 ,  A23V2250/0616 ,  A23V2250/0612 ,  A23V2250/16 ,  A23V2250/1578 ,  A23V2250/161 ,  A23V2250/1612 ,  A23V2250/1592 ,  A23V2250/1588 ,  A23V2250/1642 ,  A23V2250/06 ,  A23V2250/156 ,  A23V2250/702 ,  A23V2250/704 ,  A23V2250/641 ,  A23V2250/0644

Abstract: The present invention pertains to a nutritional composition for reconstituting an optimal healthy microbiota ecosystem in humans or animals. In particular, the present invention relates to an ingestible carrier containing specific amino acids designed to favor the growth of bacteria favorable to individuals health or for reducing the risk of developing deleterious events. The invention also pertains to the use of specific amino acids for reconstituting an optimal healthy microbiota ecosystem in humans or animals, in particular in infants, critically ill patients, in the case of chronic diseases or any stresses impacting the gut and in elderly people.

Abstract translation: 本发明涉及用于重建人或动物中最佳健康微生物群落生态系统的营养组合物。 特别地，本发明涉及含有特定氨基酸的可摄入载体，其被设计为有利于有利于个人健康的细菌的生长或用于降低发生有害事件的风险。 本发明还涉及特定氨基酸用于在人或动物，特别是婴儿，危重病患者，慢性疾病或任何影响肠道和老年人的压力的情况下，重建最佳的健康微生物群落生态系统。